What is the recommended dose of Librax (chlordiazepoxide and clidinium) for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Librax (Chlordiazepoxide and Clidinium) Dosing for Adults

The recommended dosage of Librax (chlordiazepoxide hydrochloride and clidinium bromide) for adults is 1 or 2 capsules, 3 or 4 times a day, administered before meals and at bedtime. 1

Standard Dosing Guidelines

  • The usual maintenance dose is 1-2 capsules taken 3-4 times daily, specifically before meals and at bedtime 1
  • Dosing should be individualized based on patient response and clinical presentation 1
  • The medication combines chlordiazepoxide (a benzodiazepine) with clidinium (an anticholinergic agent) 1, 2

Geriatric Dosing Considerations

  • For elderly patients, dosage should be limited to the smallest effective amount to prevent ataxia, oversedation, or confusion 1
  • Initial dose for elderly patients should not exceed 2 Librax capsules per day 1
  • Dose can be gradually increased as needed and tolerated in geriatric patients 1
  • Elderly patients have an increased risk of dose-related adverse reactions 1

Pharmacokinetic Considerations

  • Chlordiazepoxide has a complex metabolic pathway with multiple active metabolites (desmethylchlordiazepoxide, demoxepam, desmethyldiazepam, and oxazepam) 2
  • The elimination half-life of chlordiazepoxide typically ranges from 5-30 hours in healthy individuals 2
  • Clearance of chlordiazepoxide is reduced and half-life is prolonged in elderly patients and those with liver cirrhosis 2, 3
  • Multiple-dose therapy results in accumulation of the parent compound and its active metabolites 2

Special Population Considerations

Patients with Hepatic Impairment

  • Use caution in patients with hepatic insufficiency as chlordiazepoxide metabolism occurs through hepatic oxidation 3
  • Delayed metabolism in hepatic impairment can lead to "dose-stacking" where unmetabolized chlordiazepoxide accumulates 3
  • This accumulated reservoir undergoes slow biotransformation to active metabolites even after dosing is discontinued 3
  • The metabolite demoxepam has a markedly longer half-life (14-95 hours) than chlordiazepoxide (6.6-28 hours), which may be further prolonged by hepatic insufficiency 3

Discontinuation Protocol

  • To reduce withdrawal reactions, use a gradual taper when discontinuing Librax 1
  • If withdrawal reactions develop, consider pausing the taper or increasing the dosage to the previous tapered level 1
  • Subsequently decrease the dosage more slowly to minimize withdrawal symptoms 1

Important Monitoring Considerations

  • Monitor for sedation, particularly when used with other central nervous system depressants 1, 4
  • Be aware that standard therapeutic doses of chlordiazepoxide (10 mg three times daily) have not been shown to potentiate the effects of moderate alcohol consumption in studies 4
  • Regular assessment for side effects related to both the benzodiazepine component (sedation, ataxia) and anticholinergic component (dry mouth, urinary hesitancy) is recommended 1

Common Pitfalls and Caveats

  • Avoid abrupt discontinuation due to risk of withdrawal symptoms 1
  • Use caution when prescribing to elderly patients due to increased sensitivity to both benzodiazepine and anticholinergic effects 1
  • Be aware of potential for dependence with long-term use of the chlordiazepoxide component 1
  • Intramuscular injection of chlordiazepoxide should be avoided as it results in slow and erratic absorption 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.